Cargando…

Tamoxifen, aminoglutethimide and danazol: effect of therapy on hormones in post-menopausal patients with breast cancer.

Gonadotrophins, oestradiol, androstenedione, testosterone and dehydroepiandrosterone sulphate (DHAS) were measured sequentially in 72 patients with advanced breast cancer receiving endocrine therapy of various types. Tamoxifen significantly reduced gonadotrophins but did not effect other hormones. D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coombes, R. C., Powles, T. J., Rees, L. H., Ratcliffe, W. A., Nash, A. G., Henk, M., Ford, H. T., Gazet, J. C., Neville, A. M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1982
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011059/ https://www.ncbi.nlm.nih.gov/pubmed/7104195

Ejemplares similares

Polymorphically acetylated aminoglutethimide in humans.
por: Coombes, R. C., et al.
Publicado: (1982)

Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer.
por: Dowsett, M., et al.
Publicado: (1984)

The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer.
por: MacNeill, F. A., et al.
Publicado: (1992)

Combined treatment with 4-hydroxyandrostenedione and aminoglutethimide: effects on aromatase inhibition and oestrogen suppression.
por: MacNeill, F. A., et al.
Publicado: (1994)

Efficacy of tamoxifen±aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial
por: Pfeiler, G, et al.
Publicado: (2013)

Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer.
por: Harris, A. L., et al.
Publicado: (1983)

Role of aminoglutethimide in male breast cancer.
por: Harris, A. L., et al.
Publicado: (1986)

Agranulocytosis associated with aminoglutethimide: pharmacological and marrow studies.
por: Harris, A. L., et al.
Publicado: (1986)

Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.
por: Ponder, B. A., et al.
Publicado: (1984)

Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen.
por: Dearnaley, D. P., et al.
Publicado: (1981)

No effect of danazol treatment in patients with advanced idiopathic pulmonary fibrosis
por: Hoffman, Thijs W., et al.
Publicado: (2023)

Metabolism of aminoglutethimide in humans: quantification and clinical relevance of induced metabolism.
por: Goss, P. E., et al.
Publicado: (1985)

Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study).
por: Gazet, J. C., et al.
Publicado: (1991)

Suppression of plasma 6-keto-prostaglandin F1 alpha and 13,14-dihydro-15-keto-prostaglandin F2 alpha by aminoglutethimide in advanced breast cancer.
por: Harris, A. L., et al.
Publicado: (1983)

Observations on the pharmacokinetics of low dose aminoglutethimide in patients with advanced breast cancer.
por: Stuart-Harris, R., et al.
Publicado: (1985)

Multicentre cross over study of aminoglutethimide and trilostane in advanced postmenopausal breast cancer.
por: Williams, C. J., et al.
Publicado: (1993)

Fibreoptic bronchoscopy as an aid to diagnosis of respiratory symptoms in breast cancer patients.
por: Morris, A. J., et al.
Publicado: (1983)

The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo.
por: Powles, T. J., et al.
Publicado: (1998)

Long-term prophylaxis of hereditary angioedema with danazol
por: Xu, Yingyang, et al.
Publicado: (2022)

Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.
por: Harris, A. L., et al.
Publicado: (1983)

Successful treatment of telomeropathy‐related interstitial lung disease with immunosuppression and danazol
por: Chambers, Daniel C., et al.
Publicado: (2020)

An assessment of the effects of hormones on short term organ cultures of human breast carcinomata.
por: Beeby, D. I., et al.
Publicado: (1975)

Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia
por: Chai, Kern Y., et al.
Publicado: (2019)

Danazol: An Effective Option in Acquired Amegakaryocytic Thrombocytopaenic Purpura
por: Mulroy, E., et al.
Publicado: (2015)

The effect of anastrozole on the pharmacokinetics of tamoxifen in post-menopausal women with early breast cancer
por: Dowsett, M, et al.
Publicado: (1999)

The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients.
por: Dowsett, M., et al.
Publicado: (1988)

Proceedings: Hormones in breast cancer patients on tamoxifen.
por: Golder, M. P., et al.
Publicado: (1975)

The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.
por: Stein, R. C., et al.
Publicado: (1990)

Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients.
por: Dowsett, M., et al.
Publicado: (1985)

A controlled trial of adjuvant tamoxifen, with or without prednisolone, in post-menopausal women with operable breast cancer.
por: Fentiman, I. S., et al.
Publicado: (1994)

Cyclical Thrombocytopenia Synchronized With the Patient’s Menstrual Cycle Treated With Danazol
por: Menakuru, Sasmith R., et al.
Publicado: (2022)

Measurement of S-phase fraction and ploidy in sequential fine-needle aspirates from primary human breast tumours treated with tamoxifen.
por: Fernando, I. N., et al.
Publicado: (1994)

A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer.
por: Powles, T. J., et al.
Publicado: (1989)

A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients.
por: Dowsett, M., et al.
Publicado: (1985)

Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with aminoglutethimide.
por: LÃ¸nning, P. E., et al.
Publicado: (1989)

Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal women.
por: Jones, A. L., et al.
Publicado: (1992)

The effect of long-term danazol treatment on haematological parameters in hereditary angioedema
por: Kőhalmi, Kinga Viktória, et al.
Publicado: (2016)

Enhanced bioavailability of danazol nanosuspensions by wet milling and high-pressure homogenization
por: Kanthamneni, Naveen, et al.
Publicado: (2016)

Danazol as a Treatment for Uterine Arteriovenous Malformation: A Case Report
por: Tak, Hyunjin, et al.
Publicado: (2023)

Factors related to the experience of menopausal symptoms in women prescribed tamoxifen
por: Moon, Zoe, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jit4f85imt3bsav5h7873mjnn2